Carboplatin Injection — FDA Drug Shortage

Current — Hospira, Inc., A Pfizer Company

The FDA lists a drug shortage record for Carboplatin Injection (injection) from Hospira, Inc., A Pfizer Company with status Current. The shortage was first posted on Apr 28, 2023. Reported reason: Other

Shortage details

Status
Current
Company
Hospira, Inc., A Pfizer Company
Package NDC
61703-339-50
Dosage Form
Injection
Presentation
Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) (NDC 61703-339-50)
Initial Posting
Apr 28, 2023

Reason

Other

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.